A recent study conducted in the country has revealed that treatment of knee osteoarthritis (OA) with single-shot visco-supplementation injection has provided significant improvement and relief to patients suffering from knee pain, a team of senior orthopaedic surgeons here said.
Giving details of the “Osteoarthritis Synvisc One Indian Study” (OASIS) study conducted on 400 patients in 14 cities across the country for 26 weeks, senior orthopaedic surgeons – Dr. Raghu Raman from Hull Royal Infirmary (UK), Dr. K.J. Reddy and Dr. Sarvajeet Pal stated on Friday that the treatment had no side effects and provided huge relief to patients.
Stating that increasing sedentary lifestyles, lack of regular physical exercise, poor diet, vitamin D deficiency were leading to osteoarthritis world over, the senior doctors assessed that about two per cent of the country’s population might be having the problem. The World Health Organisation had termed the problem as pandemic and put the number of OA patients at 16.9 million in the country in 2011.
A multi-modal approach of treatment was followed as part of the study, a non-surgical option including activity modification and physical therapy apart from injecting the drug, they explained. The drug would protect cartilage, which serves as cushion between the bones and joints, from getting damaged in the knee, they said.
Though the time of relief with the treatment was not predictable exactly, the study had proved its impact lasting from 6 to 18 months in most of the cases, the senior orthopaedic surgeons noted.
You can access the article at http://www.thehindu.com/todays-paper/tp-national/tp-newdelhi/article3289205.eceLeave a reply →